Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 3 Medulloblastoma 2 Glioma 2 Diffuse Intrinsic Pontine Glioma 2 Xanthomatosis, Cerebrotendinous 1 Urinary Bladder Neoplasms 1 Recurrence 1 Oligodendroglioma 1 Melanoma 1 Influenza, Human 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Breast Neoplasms 1 Advanced Fallopian Tube Carcinoma 1

Interventions

Temozolomide 73 Radiotherapy 33 Carboplatin 21 Bevacizumab 18 Irinotecan 16 Carmustine 16 Magnetic Resonance Spectroscopy 15 Vincristine 14 Surgical Procedures, Operative 13 Filgrastim 13 Procarbazine 10 Erlotinib Hydrochloride 8 Cyclophosphamide 8 Peripheral Blood Stem Cell Transplantation 7 O(6)-benzylguanine 7 Lomustine 7 Etoposide 7 sargramostim 6 Imatinib Mesylate 6 Flucytosine 6 Cisplatin 6 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 6 temsirolimus 5 Vorinostat 5 Thiotepa 5 Radiotherapy, Intensity-Modulated 5 Radiation 5 Biopsy 5 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 5 vocimagene amiretrorepvec 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Oligodendroglioma × Diphtheria-Tetanus Vaccine × Clear all

NCT06254326 2026-05-27

ADAGiO

University of Florida

Phase 1 Recruiting

Brain Neoplasms, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡